Evidence map›Paper›PMID 28883796›Full record

ReviewFrontiers in physiology2017

Functions of NQO1 in Cellular Protection and CoQ

David Ross, David Siegel

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 1 synthesis or guideline pooled it, 302 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. An Antioxidant Cocktail ofAntioxidants (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Review
  9. Controlled Self-Immolative Release of β-Lapachone via an OptimizedJournal of the American Chemical Society · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David RossDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical CampusAurora, CO, United States.
David SiegelDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical CampusAurora, CO, United States.
University of Colorado Anschutz Medical Campus · US

Funding

Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitorsR01CA051210 · NCI · UNIVERSITY OF COLORADO DENVER · PI ROSS, DAVID · 1990 to 2017
$5.0M
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1R01DK109964 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI DE CABO, RAFAEL, FRITZ, KRISTOFER S · 2017 to 2021
$1.9M
NCI NIH HHS R01 CA051210NIDDK NIH HHS R01 DK109964
6 · The paper itself

Abstract

NQO1 is one of the two major quinone reductases in mammalian systems. It is highly inducible and plays multiple roles in cellular adaptation to stress. A prevalent polymorphic form of NQO1 results in an absence of NQO1 protein and activity so it is important to elucidate the specific cellular functions of NQO1. Established roles of NQO1 include its ability to prevent certain quinones from one electron redox cycling but its role in quinone detoxification is dependent on the redox stability of the hydroquinone generated by two-electron reduction. Other documented roles of NQO1 include its ability to function as a component of the plasma membrane redox system generating antioxidant forms of ubiquinone and vitamin E and at high levels, as a direct superoxide reductase. Emerging roles of NQO1 include its function as an efficient intracellular generator of NAD

Indexed as

coenzyme Qpolymorphismquinone reductasesquinonessingle nucleotidesuperoxidevitamin E

Identifiers

PMID28883796
PMCPMC5573868
OpenAlexW2748512916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.